ALK tyrosine kinase inhibitors (TKIs) sequencing
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALK tyrosine kinase inhibitors (TKIs) sequencing, covering 2022-07-13 to 2022-07-13. Get the full timeline:
Most recent: Clinical Trial Update: Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.